GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Gross Margin %

Cantourage Group SE (XTER:HIGH) Gross Margin % : 0.00% (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Cantourage Group SE's Gross Profit for the six months ended in Jun. 2023 was €0.60 Mil. Cantourage Group SE's Revenue for the six months ended in Jun. 2023 was €0.60 Mil. Therefore, Cantourage Group SE's Gross Margin % for the quarter that ended in Jun. 2023 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Cantourage Group SE's Gross Margin % or its related term are showing as below:


During the past 4 years, the highest Gross Margin % of Cantourage Group SE was 35.14%. The lowest was 19.06%. And the median was 27.10%.

XTER:HIGH's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 47.04
* Ranked among companies with meaningful Gross Margin % only.

Cantourage Group SE had a gross margin of N/A% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Cantourage Group SE was 0.00% per year.


Cantourage Group SE Gross Margin % Historical Data

The historical data trend for Cantourage Group SE's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE Gross Margin % Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Gross Margin %
- 19.06 35.14 -

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
Gross Margin % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Cantourage Group SE's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's Gross Margin % falls into.



Cantourage Group SE Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Cantourage Group SE's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=0.6 / 0.603
=(Revenue - Cost of Goods Sold) / Revenue
=(0.603 - 0) / 0.603
=N/A %

Cantourage Group SE's Gross Margin for the quarter that ended in Jun. 2023 is calculated as


Gross Margin % (Q: Jun. 2023 )=Gross Profit (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=0.6 / 0.599
=(Revenue - Cost of Goods Sold) / Revenue
=(0.599 - 0) / 0.599
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Cantourage Group SE  (XTER:HIGH) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cantourage Group SE had a gross margin of N/A% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Cantourage Group SE Gross Margin % Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantourage Group SE (XTER:HIGH) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines